ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway
Sha Li(Kunming University of Science and Technology), Jinhua Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 67
Related Papers
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
|Drug Resistance Updates|2023|236
Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells
|Free Radical Biology and Medicine|2017|136
CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
|Journal of Translational Medicine|2022|112
Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA
|Gene|2013|78
Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis
|Acta Pharmacologica Sinica|2022|77